Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of NovoSeven® (Activated Recombinant Human Factor VII): Non-interventional Study in Patients With Congenital Haemophilia With Inhibitors, Acquired Haemophilia, Factor FVII Deficiency, and Glanzmann's Thrombasthenia

NCT00697320 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00697320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00697320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of NovoSeven® (Activated Recombinant Human Factor VII): Non-interventional Study in Patients With Congenital Haemophilia With Inhibitors, Acquired Haemophilia, Factor FVII Deficiency, and Glanzmann's Thrombasthenia
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
December 31, 2010
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired bleeding disorder, acquired haemophilia, congenital bleeding disorder, congenital fvii deficiency, glanzmann's disease